U.S. FTC launches inquiry into infant formula crisis

U.S. FTC launches inquiry into infant formula crisis

May 24, 2022; 3:38 PM EDT

(Reuters) – The Federal Trade Commission said on Tuesday it has launched an inquiry into the ongoing shortage for infant formula.

Empty shelves show a shortage of baby formula at a CVS store in San Antonio, Texas, U.S. May 10, 2022. REUTERS/Kaylee Greenlee Beal

The inquiry comes in the wake of a product recall by top baby formula maker Abbott Laboratories (ABT.N) and the closing of its manufacturing plant in Sturgis, Michigan during a probe by the U.S. Food and Drug Administration that has created one of the biggest infant formula shortages in recent history for U.S. families.

Reporting by Ananya Mariam Rajesh in Bengaluru; Editing by Arun Koyyur

Our Standards: The Thomson Reuters Trust Principles.

 

Reuters source:

https://www.reuters.com/world/us/us-ftc-launches-inquiry-into-infant-formula-crisis-2022-05-24

 

/by
You might also like
Astellas FDA green lights Astellas' trial for Pompe disease therapeutic
brain scan Third patient death potentially linked to lecanemab days before expected FDA decision
FDA U.S. FDA declines to approve expanded use of Acadia's antipsychotic drug
FDAReuters FDA withdraws approval for TG Therapeutics cancer treatment
Dupixent FDA approves Dupixent as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
Abbott Abbott to add 1,000 jobs in $450 million Irish investment
Sanofi, Sobi and Midatech Gain FDA's Vote of Confidence in Hemophilia, Cancer
FDA, stop sign In latest PARP probe, FDA asks Clovis to limit Rubraca’s label